Increase of capsaicin-induced trigeminal Fos-like immunoreactivity by 5-HT7 receptors

Headache

Volumn 51, Issue 10, 2011, Pages 1511-1519

  Martínez García, Esther ^a   Leopoldo, Marcello ^b   Lacivita, Enza ^b   Terrõn, José A ^a  

^a DEPARTAMENTO DE FÍSICA   (Mexico)

^b UNIVERSITY OF BARI   (Italy)

Author keywords

5 hydroxytryptamine7 receptor; capsaicin; cephalic pain; Fos like immunoreactivity; rat; trigeminal nucleus caudalis

Indexed keywords

CAPSAICIN; DRUG VEHICLE; LP 211; SB 656104; SEROTONIN 7 RECEPTOR; SEROTONIN AGONIST; SEROTONIN ANTAGONIST; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENCEPHALE ISOLE; IMMUNOREACTIVITY; MALE; NONHUMAN; OLIVARY NUCLEUS; ONCOGENE C FOS; ORGANUM VASCULOSUM OF THE LAMINA TERMINALIS; PHARMACOLOGICAL STIMULATION; PRIORITY JOURNAL; RAT; SENSORY NERVE CELL;

ANIMALS; CAPSAICIN; MALE; PROTO-ONCOGENE PROTEINS C-FOS; RATS; RATS, WISTAR; RECEPTORS, SEROTONIN; TRIGEMINAL CAUDAL NUCLEUS;

EID: 81255124339     PISSN: 00178748     EISSN: 15264610     Source Type: Journal    
DOI: 10.1111/j.1526-4610.2011.02011.x     Document Type: Article

References (48)

1. Moskowitz MA,. Basic mechanisms in vascular headache. Neurol Clin. 1990; 8: 801-815. (Pubitemid 20360044)
2. Mayberg MR, Zervas NT, Moskowitz MA,. Trigeminal projections to supratentorial pial and dural blood vessels in cats demonstrated by horseradish peroxidase histochemistry. J Comp Neurol. 1984; 223: 46-56. (Pubitemid 14186772)
3. Li YQ, Takada M, Ohishi H, Shinonaga Y, Mizuno N,. Trigeminal ganglion neurons which project by way of axon collaterals to both the caudal spinal trigeminal and the principal sensory trigeminal nuclei. Brain Res. 1992; 594: 155-159.
4. Tsai SH, Tew JM, McLean JH, Shipley MT,. Cerebral arterial innervation by nerve fibers containing calcitonin gene-related peptide (CGRP): I. Distribution and origin of CGRP perivascular innervation in the rat. J Comp Neurol. 1988; 271: 435-444.
5. Hunt SP, Pini A, Evan G,. Induction of c-fos-like protein in spinal cord neurons following sensory stimulation. Nature. 1987; 328: 632-634. (Pubitemid 17103967)
6. Cutrer FM, Moussaoui S, Garret C, Moskowitz MA,. The nonpeptide neurokinin-1 antagonist, RPR 100893, decreases c-fos expression in trigeminal nucleus caudalis following noxious chemical meningeal stimulation. Neuroscience. 1995; 64: 741-750.
7. Mitsikostas DD, Sanchez del Rio M, Waeber C, Moskowitz MA, Cutrer FM,. The NMDA receptor antagonist MK-801 reduces capsaicin-induced c-fos expression within rat trigeminal nucleus caudalis. Pain. 1998; 76: 239-248. (Pubitemid 28304962)
8. Nozaki K, Boccalini P, Moskowitz MA,. Expression of c-fos-like immunoreactivity in brainstem after meningeal irritation by blood in the subarachnoid space. Neuroscience. 1992; 49: 669-680.
9. Kaube H, Keay KA, Hoskin KL, Bandler R, Goadsby PJ,. Expression of c-Fos-like immunoreactivity in the caudal medulla and upper cervical spinal cord following stimulation of the superior sagittal sinus in the cat. Brain Res. 1993; 629: 95-102.
10. Hoskin KL, Kaube H, Goadsby PJ,. Sumatriptan can inhibit trigeminal afferents by an exclusively neural mechanism. Brain. 1996; 119: 1419-1428. (Pubitemid 26375714)
11. Strassman AM, Mineta Y, Vos BP,. Distribution of fos-like immunoreactivity in the medullary and upper cervical dorsal horn produced by stimulation of dural blood vessels in the rat. J Neurosci. 1994; 14: 3725-3735. (Pubitemid 24174119)
12. Nozaki K, Moskowitz MA, Boccalini P,. CP-93,129, sumatriptan, dihydroergotamine block c-fos expression within rat trigeminal nucleus caudalis caused by chemical stimulation of the meninges. Br J Pharmacol. 1992; 106: 409-415.
13. Mitsikostas DD, Sanchez del Rio M,. Receptor systems mediating c-fos expression within trigeminal nucleus caudalis in animal models of migraine. Brain Res Rev. 2001; 35: 20-35. (Pubitemid 32203700)
14. Jensen K, Tuxen C, Pedersen-Bjergaard U, Jansen I, Edvinsson L, Olesen J,. Pain, wheal and flare in human forearm skin induced by bradykinin and 5-hydroxytryptamine. Peptides. 1990; 11: 1133-1138.
15. Sufka KJ, Schomburg FM, Giordano J,. Receptor mediation of 5-HT-induced inflammation and nociception in rats. Pharmacol Biochem Behav. 1991; 41: 53-56.
16. Taiwo YO, Levine JD,. Serotonin is a directly-acting hyperalgesic agent in the rat. Neuroscience. 1992; 48: 485-490.
17. 1A receptor agonist 8-OH-2-(di-n-propylamino)tetralin on nociceptive sensitivity in mice. Pharmacol Biochem Behav. 1986; 25: 883-888. (Pubitemid 17179909)
18. Taiwo YO, Heller PH, Levine JD,. Mediation of serotonin hyperalgesia by the cAMP second messenger system. Neuroscience. 1992; 48: 479-483.
19. 7 receptors are involved in mediating 5-HT-induced activation of rat primary afferent neurons. Life Sci. 2002; 71: 2279-2289. (Pubitemid 35246216)
20. 7 receptors in the formalin test. Pain. 2005; 117: 182-192. (Pubitemid 41764786)
21. Cardenas LM, Cardenas CG, Scroggs RS,. 5-HT increases excitability of nociceptor-like rat dorsal root ganglion neurons via cAMP-coupled TTX-resistant Na(+) channels. J Neurophysiol. 2001; 86: 241-248. (Pubitemid 32623229)
22. Terrõn JA, Bouchelet I, Hamel E,. 5-HT(7) receptor mRNA expression in human trigeminal ganglia. Neurosci Lett. 2001; 302: 9-12. (Pubitemid 32244184)
23. Levy D, Strassman AM,. Distinct sensitizing effects of the cAMP-PKA second messenger cascade on rat dural mechanonociceptors. J Physiol. 2002; 538: 483-493. (Pubitemid 35175375)
24. Ruat M, Traiffort E, Leurs R, et al,. Molecular cloning, characterization, and localization of a high-affinity serotonin receptor (5-HT7) activating cAMP formation. Proc Natl Acad Sci U S A. 1993; 90: 8547-8551. (Pubitemid 23277706)
25. 7 Receptors of Capsaicin-Induced c-fos Expression in the Trigeminal Nucleus Caudalis of Anesthetized Rats. Program No. 266.20. 2009 Neuroscience Meeting Planner. Chicago, IL: Society for Neuroscience; 2009.
26. Cutrer FM, Limmroth V, Ayata G, Moskowitz MA,. Attenuation by valproate of c-fos immunoreactivity in trigeminal nucleus caudalis induced by intracisternal capsaicin. Br J Pharmacol. 1995; 116: 3199-3204. (Pubitemid 26007763)
27. Cutrer FM, Schoenfeld D, Limmroth V, Panahian N, Moskowitz MA,. Suppression by the sumatriptan analogue, CP-122,288 of c-fos immunoreactivity in trigeminal nucleus caudalis induced by intracisternal capsaicin. Br J Pharmacol. 1995; 114: 987-992.
28. Kemper RH, Meijler WJ, Ter Horst GJ,. Trigeminovascular stimulation in conscious rats. Neuroreport. 1997; 8: 1123-1126. (Pubitemid 27198581)
29. Ter Horst GJ, Meijler WJ, Korf J, Kemper RH,. Trigeminal nociception-induced cerebral Fos expression in the conscious rat. Cephalalgia. 2001; 21: 963-975. (Pubitemid 34626033)
30. Forbes IT, Douglas S, Gribble AD, et al,. SB-656104-A: A novel 5-HT(7) receptor antagonist with improved in vivo properties. Bioorg Med Chem Lett. 2002; 12: 3341-3344. (Pubitemid 35248245)
31. 7 receptor activity. Part III. J Med Chem. 2008; 51: 5813-5822.
32. Hedlund PB, Leopoldo M, Caccia S, et al,. LP-211 is a brain penetrant selective agonist for the serotonin 5-HT(7) receptor. Neurosci Lett. 2010; 481: 12-16.
33. 7 receptor involved in the pathogenesis and prophylactic treatment of migraine? Eur J Pharmacol. 2002; 439: 1-11. (Pubitemid 34286600)
34. Horisawa T, Ishibashi T, Nishikawa H, et al,. The effects of selective antagonists of serotonin 5-HT(7) and 5-HT(1A) receptors on MK-801-induced impairment of learning and memory in the passive avoidance and Morris water maze tests in rats: Mechanistic implications for the beneficial effects of the novel atypical antipsychotic lurasidone. Behav Brain Res. 2011; 220: 83-90.
35. Presley RW, Menétrey D, Levine JD, Basbaum AI,. Systemic morphine suppresses noxious stimulus-evoked Fos protein-like immunoreactivity in the rat spinal cord. J Neurosci. 1990; 10: 323-335. (Pubitemid 20059269)
36. Hoskin KL, Zagami AS, Goadsby PJ,. Stimulation of the middle meningeal artery leads to Fos expression in the trigeminocervical nucleus: A comparative study of monkey and cat. J Anat. 1999; 194: 579-588. (Pubitemid 29335626)
37. Shepheard SL, Williamson DJ, Williams J, Hill RG, Hargreaves RJ,. Comparison of the effects of sumatriptan and the NK1 antagonist CP-99,994 on plasma extravasation in Dura mater and c-fos mRNA expression in trigeminal nucleus caudalis of rats. Neuropharmacology. 1995; 34: 255-261.
38. Pierce PA, Xie GX, Meuser T, Peroutka SJ,. 5-Hydroxytryptamine receptor subtype messenger RNAs in human dorsal root ganglia: A polymerase chain reaction study. Neuroscience. 1997; 81: 813-819. (Pubitemid 27402525)
39. Pierce PA, Xie GX, Levine JD, Peroutka SJ,. 5-Hydroxytryptamine receptor subtype messenger RNAs in rat peripheral sensory and sympathetic ganglia: A polymerase chain reaction study. Neuroscience. 1996; 70: 553-559.
40. Pierce PA, Xie GX, Peroutka SJ, Levine JD,. Dual effect of the serotonin agonist, sumatriptan, on peripheral neurogenic inflammation. Reg Anesth. 1996; 21: 219-225. (Pubitemid 26152761)
41. Dimitriadou V, Buzzi MG, Moskowitz MA, Theoharides TC,. Trigeminal sensory fiber stimulation induces morphological changes reflecting secretion in rat dura mater mast cells. Neuroscience. 1991; 44: 97-112.
42. Buzzi MG, Dimitriadou V, Theoharides TC, Moskowitz MA,. 5-Hydroxytryptamine receptor agonists for the abortive treatment of vascular headaches block mast cell, endothelial and platelet activation within the rat dura mater after trigeminal stimulation. Brain Res. 1992; 583: 137-149.
43. Bolay H, Reuter U, Dunn AK, Huang Z, Boas DA, Moskowitz MA,. Intrinsic brain activity triggers trigeminal meningeal afferents in a migraine model. Nat Med. 2002; 8: 136-142. (Pubitemid 34155124)
44. Pietrobon D, Striessnig J,. Neurobiology of migraine. Nat Rev Neurosci. 2003; 4: 386-398. (Pubitemid 37280177)
45. Ottosson A, Edvinsson L,. Release of histamine from dural mast cells by substance P and calcitonin gene-related peptide. Cephalalgia. 1997; 17: 166-174. (Pubitemid 27257341)
46. Rozniecki JJ, Dimitriadou V, Lambracht-Hall M, Pang X, Theoharides TC,. Morphological and functional demonstration of rat dura mater mast cell-neuron interactions in vitro and in vivo. Brain Res. 1999; 849: 1-15.
47. 7 Receptor-Mediated Dilatation in the Middle Meningeal Artery of Anesthetized Rats. Program No.799.2. 2010 Neuroscience Meeting Planner. San Diego, CA: Society for Neuroscience; 2010. Online.
48. 7 receptor reduces CGRP release in an experimental model for migraine. Headache. 2010; 50: 579-587.